Deltex Medical Group PLC Issue of Equity (2057A)
January 18 2024 - 11:01AM
UK Regulatory
TIDMDEMG
RNS Number : 2057A
Deltex Medical Group PLC
18 January 2024
18 January 2024
Deltex Medical Group plc
("Deltex Medical", the "Company" or the "Group")
Issue of equity to satisfy equity-settled non-executive
directors' fees
The Board of Deltex Medical (AIM: DEMG), announces the issue of
49,372,352 new ordinary shares of 1p each in the capital of the
Company (the "Ordinary Shares"), at an issue price of 0.17 pence
per new Ordinary Share (the "Issue Price"). The Issue Price
represents the Company's closing mid-market price on 17 January
2024.
The new Ordinary Shares are being issued in order to satisfy the
fees of certain current and former non-executive directors for the
year ending 31 December 2023 ("Fee Shares"), as has been done in
previous years.
A total of 12,941,176 Fee Shares will be issued to former
non-executive director Mark Wippell and a total of36,431,176 Fee
Shares will be issued to current non-executive directors as set out
below:
Resultant holding post Fee
Shares
Director Current Fee Shares Ordinary As a percentage
Ordinary issued Shares held of the enlarged
Shares held share capital on
Admission
Nigel
Keen 332,267,649 22,313,529 354,581,178 18.70%
Chris
Jones 6,479,109 14,117,647 20,596,756 1.09%
Under the contract with Nigel Keen, he or the Company can opt to
settle his fees (plus employer's national insurance) by the issue
of new ordinary shares at the share price at the time of issue and
the same applies to Chris Jones' and Ben Carswell's contracts for
up to half of their fees. These share issues are expected to occur
on an annual basis when permitted.
Application for admission to trading and total voting rights
Application has been made for 49,372,352 new Ordinary Shares to
be admitted to trading on AIM, which is expected to take effect on
or around 24 January 2024 ("Admission").
Following Admission, the Company's issued share capital will
comprise 1,896,025,700 Ordinary Shares. The Company does not hold
any Ordinary Shares in treasury. This figure may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of
the Company under the Financial Conduct Authority's Disclosure
Guidance and Transparency Rules.
For further information, please contact:
Deltex Medical Group plc 01243 774 837
Nigel Keen, Chairman investorinfo@Deltexmedical.com
Andy Mears, Chief Executive
Natalie Wettler, Group Finance Director
Nominated Adviser and Broker
Allenby Capital Limited 020 3328 5656
Jeremy Porter / Vivek Bhardwaj (Corporate info@allenbycapital.com
Finance)
Tony Quirke / Stefano Aquilino (Sales
& Corporate Broking)
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them:
1. Details of the person discharging managerial responsibilities
/ person closely associated
a) Name PDMRs: Nigel Keen Non-Executive Director
- Chairman
Chris Jones Non-Executive Director
-----------------------
-------------------------------- --------------------------------------------
2. Reason for the Notification
------------------------------------------------------------------------------
a) Position/status See 1a) above
-------------------------------- --------------------------------------------
b) Initial notification/Amendment Initial Notification
-------------------------------- --------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------
a) Name Deltex Medical Group Plc
-------------------------------- --------------------------------------------
b) LEI 213800XN34P6LI8J6M39
-------------------------------- --------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------
a) Description of Ordinary shares of 0.1p each in
the Financial Deltex Medical Group Plc
instrument, type
of instrument
-------------------------------- --------------------------------------------
Identification ISIN: GB0059337583
code
-------------------------------- --------------------------------------------
b) Nature of the Fee shares
transaction
-------------------------------- --------------------------------------------
c) Price(s) and volume(s) Name Price(s) Volume(s)
Nigel Keen 0.17p 22,313,529
--------- -----------
Chris Jones 0.17p 14,117,647
--------- -----------
-------------------------------- --------------------------------------------
d) Aggregated information:
-------------------------------- --------------------------------------------
* Aggregated volume 36,431,176
------------------------------------- --------------------------------------------
* Price 0.17p
------------------------------------- --------------------------------------------
e) Date of the transaction 18 January 2024
-------------------------------- --------------------------------------------
f) Place of the transaction Outside a trading venue
-------------------------------- --------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOESFUFMAELSEIF
(END) Dow Jones Newswires
January 18, 2024 12:01 ET (17:01 GMT)
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From Apr 2023 to Apr 2024
